David S. Millan

1.0k total citations
23 papers, 681 citations indexed

About

David S. Millan is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David S. Millan has authored 23 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David S. Millan's work include Inhalation and Respiratory Drug Delivery (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Marine Sponges and Natural Products (4 papers). David S. Millan is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Marine Sponges and Natural Products (4 papers). David S. Millan collaborates with scholars based in United Kingdom, United States and Australia. David S. Millan's co-authors include Alexander Alex, Manuel Pérez, Florian Wakenhut, Gavin A. Whitlock, Rolf H. Prager, Andrew J. P. White, D. Christopher Braddock, Tao Ye, Alleyn T. Plowright and Miguel A. González and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

David S. Millan

21 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Millan United Kingdom 13 352 287 104 61 52 23 681
Olivier Corminboeuf Switzerland 16 349 1.0× 231 0.8× 82 0.8× 62 1.0× 55 1.1× 24 666
Alexander G. Dossetter United Kingdom 17 627 1.8× 219 0.8× 169 1.6× 87 1.4× 87 1.7× 24 886
C. John Blankley United States 17 510 1.4× 419 1.5× 123 1.2× 41 0.7× 90 1.7× 33 1.0k
Miles G. Siegel United States 11 390 1.1× 492 1.7× 182 1.8× 32 0.5× 60 1.2× 22 812
Zhaoqiang Chen China 19 473 1.3× 337 1.2× 90 0.9× 25 0.4× 75 1.4× 34 1.1k
John G. Cumming United Kingdom 17 500 1.4× 295 1.0× 222 2.1× 114 1.9× 87 1.7× 30 881
Run‐Ling Wang China 20 322 0.9× 782 2.7× 193 1.9× 36 0.6× 73 1.4× 77 1.2k
Dafydd R. Owen United Kingdom 19 596 1.7× 804 2.8× 90 0.9× 22 0.4× 45 0.9× 33 1.4k
Carl Berthelette Canada 19 428 1.2× 200 0.7× 32 0.3× 21 0.3× 84 1.6× 25 705
André Alker Switzerland 14 364 1.0× 243 0.8× 47 0.5× 20 0.3× 34 0.7× 31 695

Countries citing papers authored by David S. Millan

Since Specialization
Citations

This map shows the geographic impact of David S. Millan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Millan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Millan more than expected).

Fields of papers citing papers by David S. Millan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Millan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Millan. The network helps show where David S. Millan may publish in the future.

Co-authorship network of co-authors of David S. Millan

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Millan. A scholar is included among the top collaborators of David S. Millan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Millan. David S. Millan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bhatta, Maulasri, Betty Chan, Christophe Marzac, et al.. (2024). AUTX703, a Novel and Potent KAT2A and KAT2B Protein Degrader, Induces Differentiation and Offers Survival Advantage in a Primary Human AML Xenograft Model. Blood. 144(Supplement 1). 3585–3585. 1 indexed citations
3.
Straley, Kimberly, Iléana Antony‐Debré, Maulasri Bhatta, et al.. (2024). Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems. Cancer Research. 84(6_Supplement). 5795–5795.
4.
Martin, Matthew W., David R. Lancia, Hongbin Li, et al.. (2019). Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN). Bioorganic & Medicinal Chemistry Letters. 29(8). 1001–1006. 13 indexed citations
5.
Millan, David S., Katherine J. Kayser-Bricker, Matthew W. Martin, et al.. (2017). Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains. ACS Medicinal Chemistry Letters. 8(8). 847–852. 14 indexed citations
6.
7.
Knight, Craig J., et al.. (2012). Kilogram-Scale Synthesis of an Inhaled Corticosteroid. Organic Process Research & Development. 16(4). 697–703. 4 indexed citations
8.
Millan, David S., Stephen A. Ballard, Paul A. Glossop, et al.. (2011). Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma. Bioorganic & Medicinal Chemistry Letters. 21(19). 5826–5830. 11 indexed citations
9.
Hughes, Samantha Jane, David S. Millan, Iain Kilty, et al.. (2011). Fragment based discovery of a novel and selective PI3 kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(21). 6586–6590. 29 indexed citations
10.
Alex, Alexander, David S. Millan, Manuel Pérez, Florian Wakenhut, & Gavin A. Whitlock. (2011). Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space. MedChemComm. 2(7). 669–669. 247 indexed citations
11.
Millan, David S., Mark E. Bunnage, Jane L. Burrows, et al.. (2011). Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry. 54(22). 7797–7814. 76 indexed citations
12.
Millan, David S.. (2011). What is the Potential for Inhaled P38 Inhibitors in the Treatment of Chronic Obstructive Pulmonary Disease?. Future Medicinal Chemistry. 3(13). 1635–1645. 19 indexed citations
13.
Braddock, D. Christopher, David S. Millan, Yolanda Pérez-Fuertes, et al.. (2006). A Biosynthetically-Inspired Synthesis of the Tetrahydrofuran Core of Obtusallenes II and IV. Organic Letters. 9(3). 445–448. 30 indexed citations
14.
Pattenden, Gerald, Miguel A. González, Paul B. Little, et al.. (2003). Total synthesis of (+)-phorboxazole A, a potent cytostatic agent from the sponge Phorbas sp.. Organic & Biomolecular Chemistry. 1(23). 4173–4208. 83 indexed citations
15.
Millan, David S., et al.. (2001). THE DEALKYLATION OF TERTIARY AMINES WITH THIOPHOSGENE AND 1-CHLOROETHYL CHLOROTHIONOFORMATE. 12(1). 27–31. 1 indexed citations
16.
Millan, David S. & Rolf H. Prager. (2000). Potential GABA B Receptor Antagonists. XI. Synthesis of a Small Library of Sulfonamide Analogues. Australian Journal of Chemistry. 53(7). 615–618. 3 indexed citations
17.
Millan, David S. & Rolf H. Prager. (1999). Phenyl Chloro(thionoformate): a New Dealkylating Agent of Tertiary Amines. Australian Journal of Chemistry. 52(9). 841–850. 6 indexed citations
18.
Millan, David S. & Rolf H. Prager. (1998). The chemistry of 5-oxodihydroisoxazoles. Part 22.1 The synthesis of 1,3-oxazin-6-ones from N-thioacylisoxazol-5(2H )-ones. Journal of the Chemical Society Perkin Transactions 1. 3245–3252. 8 indexed citations
19.
Millan, David S. & Rolf H. Prager. (1998). The dealkylation of tertiary aliphatic amines with phenyl chlorothionoformate. Tetrahedron Letters. 39(24). 4387–4390. 17 indexed citations
20.
Millan, David S., et al.. (1997). Planar tether control groups and π-facial selectivity: Intramolecular cycloadditions for polycyclic systems. Tetrahedron Letters. 38(5). 795–798. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Corminboeuf Breakdown of academic impact, for papers by Alexander G. Dossetter Breakdown of academic impact, for papers by C. John Blankley Breakdown of academic impact, for papers by Miles G. Siegel Breakdown of academic impact, for papers by Zhaoqiang Chen Breakdown of academic impact, for papers by John G. Cumming Breakdown of academic impact, for papers by Run‐Ling Wang Breakdown of academic impact, for papers by Dafydd R. Owen Breakdown of academic impact, for papers by Carl Berthelette Breakdown of academic impact, for papers by André Alker
Rankless by CCL
2026